Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A STUMP

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 8, 2016
Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacologyCraig A Stump, Andrew J Cooke, Joseph Bruno, et al.
Bioorganic & Medicinal Chemistry Letters|July 10, 2007
Caprolactams as potent CGRP receptor antagonists for the treatment of migraineAnthony W Shaw, Daniel V Paone, Diem N Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2006
Benzodiazepine calcitonin gene-related peptide (CGRP) receptor antagonists: optimization of the 4-substituted piperidineChristopher S Burgey, Craig A Stump, Diem N Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2009
Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibilityMichael R Wood, Kathy M Schirripa, June J Kim, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2006
Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone leadTheresa M Williams, Craig A Stump, Diem N Nguyen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor AntagonistIan M Bell, Steven N Gallicchio, Michael R Wood, et al.
The Heart Surgery Forum|May 7, 2010
Consensus statement: minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypassR Clive Landis, John M Murkin, David A Stump, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2008
The discovery of highly potent CGRP receptor antagonistsCraig A Stump, Ian M Bell, Rodney A Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in ratsIan M Bell, Craig A Stump, Steven N Gallicchio, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2010
Identification of potent, highly constrained CGRP receptor antagonistsCraig A Stump, Ian M Bell, Rodney A Bednar, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry Letters|November 8, 2016
Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacologyCraig A Stump, Andrew J Cooke, Joseph Bruno, et al.
Bioorganic & Medicinal Chemistry Letters|July 10, 2007
Caprolactams as potent CGRP receptor antagonists for the treatment of migraineAnthony W Shaw, Daniel V Paone, Diem N Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2006
Benzodiazepine calcitonin gene-related peptide (CGRP) receptor antagonists: optimization of the 4-substituted piperidineChristopher S Burgey, Craig A Stump, Diem N Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2009
Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibilityMichael R Wood, Kathy M Schirripa, June J Kim, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2006
Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone leadTheresa M Williams, Craig A Stump, Diem N Nguyen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor AntagonistIan M Bell, Steven N Gallicchio, Michael R Wood, et al.
The Heart Surgery Forum|May 7, 2010
Consensus statement: minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypassR Clive Landis, John M Murkin, David A Stump, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2008
The discovery of highly potent CGRP receptor antagonistsCraig A Stump, Ian M Bell, Rodney A Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in ratsIan M Bell, Craig A Stump, Steven N Gallicchio, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2010
Identification of potent, highly constrained CGRP receptor antagonistsCraig A Stump, Ian M Bell, Rodney A Bednar, et al.
Pageof 13